Guardian Pharmacy Services, Inc.
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 1.00B | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | 1.00B | |
| Cost of Revenue | -- | -- | -- | 799.51M | |
| Gross Profit | -- | -- | -- | 202.51M | |
| SG&A Expenses | -- | -- | -- | 161.03M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -- | 960.54M | |
| Operating Income | -- | -- | -- | 41.48M | |
| Income Before Tax | -- | -- | -- | 38.56M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -- | 38.56 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -14.98M | |
| Net Income | -- | -- | -- | 23.58M | |
| EBIT | -- | -- | -- | 41.48M | |
| EBITDA | -- | -- | -- | 59.24M | |
| EPS Basic | -- | -- | -- | -- | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | -- | -- | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | -- | -- | |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | 130.48% | |
